Metabolic Engineering of for the Fermentative Production of Gallic Compounds by Extending the Shikimate Pathway.

Gallic acid, gallic aldehyde, and gallic alcohol are polyphenolic compounds with promising antioxidant and therapeutic properties. Despite their biological significance, a complete microbial biosynthetic route for their production from simple carbon sources has not been established. We engineered to produce gallic acid and its two reduced derivatives a synthetic pathway extended from the shikimate pathway. Introduction of a mutant 4-hydroxybenzoate hydroxylase conferred protocatechuate hydroxylation activity in . Among tested mutants, the Y385F/L200V mutant exhibited the highest gallic acid production, reaching 4.03 g/l with a yield of 5.95% in flask cultures. To enable gallic aldehyde biosynthesis, carboxylic acid reductases (CARs) from various microbial sources were screened. Of these, MpCAR exhibited the highest catalytic activity toward gallic acid, producing 0.66 g/l of gallic aldehyde in an -deleted strain. Further reduction of gallic aldehyde to gallic alcohol was achieved using the endogenous aromatic aldehyde reductase encoded by in , as confirmed by Q-TOF mass analysis. Overexpression of encoding 3-dehydroshikimate dehydratase improved carbon flux from 3-dehydroshikimate toward PCA and significantly enhanced the gallic compound production. In 5-l fed-batch fermentation, engineered strains produced up to 12.0 g/l gallic acid, 1.14 g/l gallic aldehyde, and 172.4 AU*s gallic alcohol, respectively, representing 82-86% increases compared to flask cultures. This study reports the first complete microbial biosynthetic route for gallic acid, gallic aldehyde, and gallic alcohol from D-glucose. Our work highlights as a robust microbial platform for sustainable production of value-added gallic polyphenols through pathway design and metabolic engineering.